Kenneth O. May, 1915 – 1977

[Frontiers in Bioscience 9, 1915-1924, May 1, 2004] 1915 IN VIVO ENGINEERING OF BLOOD VESSELS

1. Abstract 2. Introduction 3. In vivo tissue engineering 4. Scaffolds designed to be remodelled 4.1. Synergraft bovine ureter 4.2. Small intestinal submucosa 4.3. Absorbable synthetic grafts 4.4. Translation to the clinic 5. Fibrocollagenous tissue tubes 5.1. Eiken’s plastic rod 5.2. Wire mesh model 5.3. Sparks’ Mandril 5.4. Subcutaneous inflatable balloon 5.5. Perloff, Omniflow and other graf...

Commencement address, Yale University School of Medicine, May 16, 1977.

I am touched and humbled by this opportunity to participate in these graduation exercises. I salute you on this wonderful occasion and I welcome the many proud relatives who have come to share it with you. During the past four years many of you have become my very close personal friends which has been a source of great satisfaction to me and has to be the major reason that keeps this particular...

Kenneth Catania

R4 Current Biology 27, R1–R18, January 9, 2017 At the time of going to press, the nominations have not included the post of a science advisor, so scientists in the US and their world-leading institutions and associations are wondering how, if at all, verifi able facts from the real world can reach the president. Writing in Science magazine, the CEO of the American Association for the Advancemen...

Kenneth M

Red Blood Cell (RBC) transfusion is a common medical procedure, which most often involves stored RBC units. During storage, RBC quality degrades due to various factors (“storage lesion”). This decreases cell viability in-vivo and thus often compromises transfusion efficacy. The degradation of any given unit of RBC solution varies according to several factors besides time (e.g., variability amon...

Kenneth J